Department of Obstetrics and Gynaecology, Odense University Hospital, Odense, Denmark.
Department of Obstetrics and Gynaecology, Turku University Hospital, Turku, Finland.
BJOG. 2016 Jan;123(1):136-42. doi: 10.1111/1471-0528.13628. Epub 2015 Sep 30.
To compare the 1-year (previously published) and 3-year objective and subjective cure rates, and complications, related to the use of a collagen-coated transvaginal mesh for anterior vaginal wall prolapse against a conventional anterior repair.
Randomised controlled study.
Six departments of obstetrics and gynaecology in Norway, Sweden, Finland, and Denmark.
A total of 138 women, of 55 years of age or older, admitted for stage ≥2 anterior vaginal wall prolapse.
The women scheduled for primary anterior vaginal wall prolapse surgery were randomised between conventional anterior colporrhaphy and surgery with a collagen-coated prolene mesh. All patients were evaluated using the Pelvic Organ Prolapse Quantification (POP-Q) assessment before and after surgery. Symptoms related to pelvic organ prolapse were evaluated using the Pelvic Floor Impact Questionnaire (PFIQ-7) and the Pelvic Floor Distress Inventory (PFDI-20).
Objective cure, defined as POP-Q stage <2 prolapse at the 1- and 3-year follow-ups. Furthermore, mesh exposure and dyspareunia were also recorded.
In total, 138 patients (70 from the mesh group versus 68 from the conventional anterior colporrhaphy group) out of 160 (86.3%) participated in the 3-year follow-up. POP-Q revealed an objective anatomic cure for 88.1 and 91.4%, respectively, in the mesh group at the 1- and 3-year follow-ups, compared with 39.9 and 41.2% in the colporrhaphy group. No difference between the groups was observed regarding PFIQ-7, PFDI-20, and Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) scores. The number of mesh exposures did not change during the study period and all exposures were minor.
Our study demonstrates that although the objective outcome was superior in the mesh group, the use of mesh had no impact on the subjective outcome.
POP-Q deteriorates after anterior prolapse surgery but remains stable in women with mesh implantation.
比较胶原蛋白涂层经阴道网片治疗前阴道壁脱垂的 1 年(之前已发表)和 3 年客观和主观治愈率以及相关并发症,与传统前修补术相比。
随机对照研究。
挪威、瑞典、芬兰和丹麦的 6 个妇产科部门。
共 138 名 55 岁及以上、患有≥2 度前阴道壁脱垂的女性。
计划行原发性前阴道壁脱垂手术的女性随机分为传统前阴道修补术和胶原蛋白涂层 prolene 网片手术。所有患者在术前和术后均采用盆腔器官脱垂定量(POP-Q)评估进行评估。使用盆腔器官脱垂影响问卷(PFIQ-7)和盆腔器官脱垂/尿失禁性功能问卷(PISQ-12)评估与盆腔器官脱垂相关的症状。
客观治愈率定义为 1 年和 3 年随访时 POP-Q 分期<2 度脱垂。此外,还记录了网片暴露和性交困难。
共有 138 例患者(网片组 70 例,传统前阴道修补术组 68 例)中的 160 例(86.3%)参加了 3 年随访。网片组在 1 年和 3 年随访时的客观解剖治愈率分别为 88.1%和 91.4%,而传统前阴道修补术组分别为 39.9%和 41.2%。两组间 PFIQ-7、PFDI-20 和 PISQ-12 评分无差异。研究期间网片暴露数量无变化,且均为轻微暴露。
我们的研究表明,尽管网片组的客观结果更好,但网片的使用对主观结果没有影响。